Skip to main content
. 2022 May 12;8(7):1070–1072. doi: 10.1001/jamaoncol.2022.1167

Figure 2. Survival Outcomes.

Figure 2.

Survival among patients receiving erdafitinib in the Flatiron Health data set compared with survival among patients receiving erdafitinib following chemotherapy after individual patient data were reconstructed from the BLC2001 trial.1 Shading represents 95% CIs.

aLog-rank test.